Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers By functional area All functional areas Clinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 The Rise of Radiotherapeutics: Brief History and Best Practices for Clinical Trials By Rupa Doshi January 5, 2023 Clinical ResearchPhase 1 - Phase 4 Premier Perspective on Biomarkers in Oncology By Rupa Doshi November 2, 2022 Clinical ResearchPhase 1 - Phase 4 Antibody-Drug Conjugates in Oncology: Key Considerations and Future Trends By Ayesha Pandit October 13, 2022 Clinical ResearchPhase 1 - Phase 4 Leveraging Real-World Data & Real-World Evidence to Support Regulatory Decision Making By Nach Davé October 3, 2022 Clinical ResearchPhase 1 - Phase 4 A Fit-for-Purpose Path Forward: Linking RWD to Your Overall Data Strategy By Nach Davé September 26, 2022 Clinical ResearchPhase 1 - Phase 4 What is Real-World Data and Evidence and How It Can Facilitate Clinical Development By Nach Davé September 19, 2022 Previous 1 2 3 4 … 50 Next ×
